Saponins are chemically a heterogeneous group of sterol glycosides and
triterpene glycosides which are common constituents of plants. One so
urce of triterpenoid saponins obtained from the bark of Quillaia sapon
aria Molina (the soap bark tree) have been known to cause substantial
enhancement of immune responses since the 1920s, Despite their use in
animal vaccines, the development of saponin-based formulations for-hum
an vaccines has been impeded by their complexity and concerns about to
xicity. This review briefly covers the use of saponins for animal vacc
ines but focuses mainly on the development of these adjuvants for use
in man. important aspects include preparation of purified or highly de
fined saponin fractions, improved understanding of the relationships b
etween adjuvant activity, toxicity and structure of saponins and formu
lation of saponins into structures with reduced toxicity such as ISCOM
s, Recent developments in the understanding of cellular interactions,
cytokine induction and the in vivo localisation of saponin containing
formulations will also be reviewed. (C) 1998 Elsevier Science B.V.